Android app on Google Play

Morgan Keegan Starts Coverage on 10 Healthcare Stocks: ABT, BSX, STJ at Outperform, JNJ, MDT at Market Perform

June 17, 2011 8:16 AM EDT Send to a Friend
Get Alerts ABT Hot Sheet
Price: $41.59 -0.74%

Rating Summary:
    10 Buy, 10 Hold, 1 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 25 | Down: 20 | New: 23
Trade ABT Now!
Join SI Premium – FREE
In the Healthcare group Friday morning, Morgan Keegan's Jan Wald initiated coverage on the following stocks:
  • Abbott Labs (NYSE: ABT) with an Outperform rating and a $61 price target
  • Boston Scientific (NYSE: BSX) with an Outperform rating and a $8 price target
  • St. Jude (NYSE: STJ) with an Outperform rating and a $60 price target
  • DexCom (Nasdaq: DXCM) with an Outperform rating and a $18 price target
  • HeartWare (Nasdaq: HTWR) with an Outperform rating and a $87 price target
  • J&J (NYSE: JNJ) with a Market Perform rating and a $70 price target
  • Medtronic (NYSE: MDT) with a Market Perform rating and a $43 price target
  • Edwards Lifesciences (NYSE: EW) with a Market Perform rating and a $97 price target
  • Thoratec (Nasdaq: THOR) with a Market Perform rating and a $35 price target
  • AtriCure (Nasdaq: ATRC) with a Market Perform rating and a $14 price target
Check out our Ratings Insider portal to get the most comprehensive and up-to-date analyst coverage on the Street.




You May Also Be Interested In


Related Categories

New Coverage

Related Entities

Morgan Keegan & Company

Add Your Comment